CAROLYN O'BRIEN: Open Payments
NPI 1548211287 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 66 payments from 14 companies in 2025. Trend: 2023 $1,551 · 2024 $1,254 · 2025 $1,513
Food & beverage: $1,494Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $436 |
| Novartis Pharmaceuticals Corporation | 14 | $197 |
| REVANCE THERAPEUTICS, INC. | 1 | $180 |
| Janssen Scientific Affairs, LLC | 1 | $147 |
| GENZYME CORPORATION | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $105 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $75 |
| UCB, Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Incyte Corporation | 2 | $32 |
Products named: RINVOQ, COSENTYX, DAXXIFY, SKYRIZI, DUPIXENT, TREMFYA, Sotyktu, ILUMYA.
Industry payments across WA — which companies pay providers there.
